Autoimmune and Paraneoplastic Myelopathies

Area of Science:

• Neurology
• Immunology

Background:

• Inflammatory myelopathies require prompt recognition for optimal patient outcomes.
• Management and prognosis of autoimmune and paraneoplastic myelopathies depend heavily on the underlying cause.
• Neurologists need a comprehensive understanding of diagnostic tools for various myelopathy contexts.

Purpose of the Study:

• To provide an outline for the diagnostic evaluation of inflammatory myelopathies.
• To detail treatment strategies for autoimmune and paraneoplastic myelopathies.
• To differentiate inflammatory myelopathies from common mimickers.

Main Methods:

• Review of clinical details, imaging findings, and diagnostic information for inflammatory myelopathies.
• Discussion of specific inflammatory conditions including multiple sclerosis, aquaporin-4 IgG seropositive neuromyelitis optica spectrum disorder, sarcoidosis, and MOG IgG associated disease.
• Highlighting common conditions that mimic inflammatory myelopathies.

Main Results:

• Specific diagnostic and management plans are essential for optimal patient outcomes in inflammatory myelopathy.
• Treatment strategies and prognosis vary significantly based on the etiology of autoimmune and paraneoplastic myelopathies.
• Understanding diagnostic nuances is key to differentiating various inflammatory myelopathies and their mimics.

Conclusions:

• A systematic approach to diagnosis and treatment is vital for managing inflammatory myelopathies.
• This review serves as a guide for neurologists encountering diverse inflammatory myelopathy cases.
• Accurate diagnosis facilitates tailored treatment, improving patient prognosis.